NEUROPSYCHOLOGICAL PERFORMANCE AND CD4 LEVELS IN HIV-1 ASYMPTOMATIC INFECTION

被引:9
|
作者
PODRAZA, AM
BORNSTEIN, RA
WHITACRE, CC
PARA, MF
FASS, RJ
RICE, RR
NASRALLAH, HA
机构
[1] OHIO STATE UNIV,DEPT PSYCHIAT,NEUROPSYCHOL LAB,COLUMBUS,OH 43210
[2] MAINE HEAD TRAUMA CTR,BANGOR,ME
[3] OHIO STATE UNIV,DEPT INTERNAL MED,COLUMBUS,OH 43210
[4] OHIO STATE UNIV,DEPT MED MICROBIOL & IMMUNOL,COLUMBUS,OH 43210
关键词
D O I
10.1080/01688639408402691
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
The performance of 68 HIV-1 seropositive asymptomatic (HIV+) subjects stratified on CD4 level were compared with 82 HIV-1 seronegative (HIV-) subjects on a battery of neuropsychological, mood state, and perceived health status measures. The neuropsychological test battery included measures of attention, reaction time, memory, intellectual ability, psychomotor speed, frontal lobe or ''executive'' function, and decision time. None of the HIV+ subjects were taking antiviral agents. The groups did not differ for age, mood state, or WAIS-R Verbal and Performance IQ scores. Due to group differences for education and weekly ethanol consumption, both variables were used as covariates in multivariate analyses of variance. Relatively few differences were observed between subgroups of HIV+ patients or between these subgroups and control subjects. These data suggest that factors other than absolute levels of immunosuppression, as expressed by CD4 levels alone, appear to be responsible for the deficits observed in HIV+ asymptomatic patients.
引用
收藏
页码:777 / 783
页数:7
相关论文
共 50 条
  • [31] Pattern of HIV viraemia and CD4 levels in relation to pregnancy in HIV-1 infected women
    Lindgren, S
    Martin, C
    Anzen, B
    Strand, H
    BredbergRaden, U
    Ehrnst, A
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1996, 28 (05) : 425 - 433
  • [32] CD4:CD8 ratio in children with perinatally acquired HIV-1 infection
    Seers, T.
    Vassallo, P.
    Pollock, K.
    Thornhill, J. P.
    Fidler, S.
    Foster, C.
    HIV MEDICINE, 2018, 19 (09) : 668 - 672
  • [33] Estimating duration of HIV infection with CD4 cell count and HIV-1 RNA at presentation
    Girardi, E
    Arici, C
    Ferrara, M
    Ripamonti, D
    Aloisi, MS
    Alessandrini, A
    Scalzini, A
    Monforte, AD
    Serraino, D
    Ippolito, G
    AIDS, 2001, 15 (16) : 2201 - 2203
  • [34] First evidence of HIV infection of CD8 lymphocyts expressing CD4 during primary HIV-1 infection
    Cochrane, A
    Hughes, GJ
    Seaton, RA
    Simmonds, P
    AIDS, 2005, 19 (11) : 1237 - 1239
  • [35] DIMINUTION OF CD4 SURFACE PROTEIN BUT NOT CD4 MESSENGER-RNA LEVELS IN MONOCYTIC CELLS INFECTED BY HIV-1
    GELEZIUNAS, R
    BOUR, S
    BOULERICE, F
    HISCOTT, J
    WAINBERG, MA
    AIDS, 1991, 5 (01) : 29 - 33
  • [36] Targeted infection of HIV-1 Env expressing cells by HIV(CD4/CXCR4) vectors reveals a potential new rationale for HIV-1 mediated down-modulation of CD4
    Ye, ZP
    Harmison, GG
    Ragheb, JA
    Schubert, M
    RETROVIROLOGY, 2005, 2 (1)
  • [37] Targeted infection of HIV-1 Env expressing cells by HIV(CD4/CXCR4) vectors reveals a potential new rationale for HIV-1 mediated down-modulation of CD4
    Zhiping Ye
    George G Harmison
    Jack A Ragheb
    Manfred Schubert
    Retrovirology, 2
  • [38] HIV-1 viral loads and CD4 levels in treated and untreated adolescents.
    Holland, CA
    Douglas, SD
    Ellenberg, J
    Wilson, C
    Abadalian, SE
    Futteman, D
    JOURNAL OF ADOLESCENT HEALTH, 1998, 22 (02) : 164 - 164
  • [39] Plasma viral load and CD4(+) lymphocytes as prognostic markers of HIV-1 infection
    Mellors, JW
    Munoz, A
    Giorgi, JV
    Margolick, JB
    Tassoni, CJ
    Gupta, P
    Kingsley, LA
    Todd, JA
    Saah, AJ
    Detels, R
    Phair, JP
    Rinaldo, CR
    ANNALS OF INTERNAL MEDICINE, 1997, 126 (12) : 946 - 954
  • [40] HUMAN TROPHOBLAST CELLS EXPRESS CD4 AND ARE PERMISSIVE FOR PRODUCTIVE INFECTION WITH HIV-1
    DAVID, FJE
    AUTRAN, B
    TRAN, HC
    MENU, E
    RAPHAEL, M
    DEBRE, P
    HSI, BL
    WEGMAN, TG
    BARRESINOUSSI, F
    CHAOUAT, G
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1992, 88 (01): : 10 - 16